CVS Caremark Corp (CVS)

CVS (NYSE:Retail)
$59.44
pos +0.07
+0.12%
Today's Range: 59.04 - 59.64 | CVS Avg Daily Volume: 5,826,500
Last Update: 05/17/13 - 4:02 PM EDT
Volume: 4,131,290
YTD Performance: 22.94%
Open: $59.33
Previous Close: $59.37
52 Week Range: $43.30 - $60.66
Oustanding Shares: 1,224,392,685
Market Cap: 72,692,193,708
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 13 14
Moderate Buy 3 3 3 3
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.30 1.28 1.26 1.25
Latest Dividend: 0.23
Latest Dividend Yield: 1.52%
Dividend Ex-Date: 04/19/13
Price Earnings Ratio: 18.50
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
18.50 18.60 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.28% 32.47% 65.71%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.00 0.25 0.08
Net Income 12.10 0.05 0.02
EPS 17.50 0.18 0.06
Earnings for CVS:
EBITDA 8.98B
Revenue 123.13B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.96 $0.97 $3.97 $4.40
Number of Analysts 9 8 11 11
High Estimate $0.98 $1.00 $4.00 $4.52
Low Estimate $0.93 $0.94 $3.92 $4.20
Prior Year $0.81 $0.85 $3.44 $3.97
Growth Rate (Year over Year) 18.38% 13.97% 15.27% 11.07%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
SeekingAlpha: Are Streaks And Current Yields The Best Metrics For Dividend Growth Investors? http://t.co/Yq7dQnFTdJ $CVS $IBM $UNP $LOW $HON
2 hours ago from Seeking Alpha
derekmreul: @greggmorton: $KO $CVS $TSCO
18 hours ago from Twitter for iPhone
BarbarianCap: RT @JohnNepkins: “@BarbarianCap: Target goes hunting in Silicon Valley, following Wal-Mart"only $WMT, $CVS, $COST and $KR to be bigger than $AMZN in 13 sales
2 days ago from Twitter for iPad
JohnNepkins: “@BarbarianCap: Target goes hunting in Silicon Valley, following Wal-Mart"only $WMT, $CVS, $COST and $KR to be bigger than $AMZN in 13 sales
2 days ago from Twitter for iPhone
ethan780: RT @AndyBiotech: @bradloncar $BAX's past spin-offs: 1992 Caremark($26.5B merger w $CVS in 2007) 1996 Allegiance($5.4B buyout by $CAH in 1998) 2000 $EW $7.6B
2 days ago from Twitter for Android
AndyBiotech: @bradloncar $BAX's past spin-offs: 1992 Caremark($26.5B merger w $CVS in 2007) 1996 Allegiance($5.4B buyout by $CAH in 1998) 2000 $EW $7.6B
2 days ago from TweetDeck
__samantha_1001: Down and out with a Man Cold. My medicine advises to not operate heavy machinery, which means I probably shouldn't trade options either $CVS
2 days ago from web
bnichols9883: $RAD don't say that I didn't tell you to buy. I've been writing articles since $1.20 and will continue till $6 $WAG $CVS #RiteAid
2 days ago from StockTwits Web
isaacalex54: RT @carpetscott: http://t.co/FafLu6rL3r $RAD new 52 week high . $RAD $WAG $CVS
2 days ago from web
carpetscott: http://t.co/FafLu6rL3r $RAD new 52 week high . $RAD $WAG $CVS
2 days ago from Twitter for Android
Update
May 09, 2013 | 8:19 AM EDT
CVS Caremark Corporation Annual Shareholder Meeting - 8:30AM

A Tale of Two Drugstores Real Money Pro($)

Bullish
Mar 14, 2013 | 7:39 AM EDT
CVS earnings estimates were increased, said UBS. Health reform and generics will benefit the company in 2014/2015. Price target is now ...
Stocks that defy correction and those ripe for correction.
Bullish
Feb 07, 2013 | 8:17 AM EST
CVS estimates were raised through 2014, Guggenheim said. Company boosted its guidance. Buy rating and new $60 price target. 

Morning Es Trading Real Money Pro($)

Short-term traders will likely give the benefit of the doubt to the bulls.
Update
Jan 09, 2013 | 7:13 AM EST
JPMorgan Global Healthcare Conference (Day 4 of 5) - 01/06/13 - 01/10/13 San Francisco, CA
Bullish
Dec 20, 2012 | 8:06 AM EST
CVS estimates were raised through 2014, Jefferies said. Company can expand margins and repurchase more shares. Buy rating and new $58 p...
Bullish
Dec 14, 2012 | 8:27 AM EST
CVS estimates were raised through 2014, Lazard said. Company boosted its guidance. Buy rating and new $48.50 price target. 
Update
Dec 13, 2012 | 6:57 AM EST
CVS Caremark Corporation Analyst Meeting - 8AM 

Columnist Conversation / Market Updates

| May 18, 2013
| 6:48 AM EDT
I greatly appreciate the team for sharing my remembrance to Alan Abelson. It really did come from the heart. I am becom...
| May 18, 2013
| 6:33 AM EDT
I approach an earnings call as I do eating a lobster: tear it apart and leave nothing for the dogs in the back alley. ...

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.